Denali Therapeutics Inc. (DNLI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 24.09 |
| Open | 24.68 |
| Bid | 24.07 x 200 |
| Ask | 24.14 x 200 |
| Day's range | 23.86 - 24.86 |
| 52-week range | 14.56 - 28.75 |
| Volume | |
| Avg. volume | 1,187,193 |
| Market cap | 3.437B |
| Beta (5Y monthly) | 1.39 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.94 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 39.43 |
ZacksDenali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
Denali Therapeutics (DNLI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Investor's Business DailyDenali Therapeutics Stock Gets Technical Rating Upgrade
Denali Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
ZacksDenali (DNLI) Outperforms Industry in 3 Months: Here's Why
Denali (DNLI) gains 11.9% in three months on positive updates on its candidates.
© 2024 Yahoo. All rights reserved.